ClinicalTrialsData

Our services helps you or your business to have access to meaningful and structured clinical trials data. #Clinicaltrials #ClinicalStudies #Healthcare #Biotec

[ClinicalTrialsData @DataTrials]

$HUGE Phase 2 Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19…NCT04619706. Estimated Primary Completion Date - August 14, 2021

[ClinicalTrialsData @DataTrials]

$HTBX Phase 1|Phase 2 A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer…NCT02439450. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$GSK Phase 2 A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness…NCT04634409. Estimated Primary Completion Date - August 25, 2021

[ClinicalTrialsData @DataTrials]

$GMAB Phase 1|Phase 2 Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors…NCT02988817. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$GALT Phase 1 A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment…NCT04332432. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$EXEL Phase 1 Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors…NCT03611595. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$ERYP Phase 3 Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC…NCT03665441. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$EQ Phase 1 A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma…NCT04007198. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$ENTA Phase 1 A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment…NCT04470388. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$EARS Phase 2 AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery…NCT03908567. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$DXCM Phase 1 SGLT2 Inhibitor Adjunctive Therapy to Closed Loop Control in Type 1 Diabetes Mellitus…NCT04201496. Estimated Primary Completion Date - August 30, 2021

[ClinicalTrialsData @DataTrials]

$DVA Phase 2 Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients…NCT04428008. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$DNLI Phase 1 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL343 in Healthy Volunteers…NCT04268784. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$DERM Phase 3 Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.…NCT04250337. Estimated Primary Completion Date - August 4, 2021

[ClinicalTrialsData @DataTrials]

$CYTK Phase 1 Safety, Tolerability and Pharmacokinetics Study of CK-3773274…NCT04783766. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$CNST Phase 1|Phase 2 A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis…NCT02158858. Estimated Primary Completion Date - August 31, 2021

[ClinicalTrialsData @DataTrials]

$CLVS Phase 1 Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer…NCT03552471. Estimated Primary Completion Date - August 29, 2021

[ClinicalTrialsData @DataTrials]

$CLDX Phase 1 A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies…NCT03329950. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$CFRX Phase 3 Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase…NCT04160468. Estimated Primary Completion Date - 08/2021

[ClinicalTrialsData @DataTrials]

$CERC Phase 1 Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma…NCT04671251. Estimated Primary Completion Date - 08/2021